Investments and Equity Method Investments (Tables)

6 Months Ended

Jun. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Investments and Equity Method Investments

Investments and equity method investments consisted of the following (in thousands):

	As of June 30,		As of December 31,
	2023		2022
Investments:
Genomatica, Inc. preferred stock	$	44,885	$	44,885
Synlogic, Inc. common stock		2,727		4,819
Synlogic, Inc. warrants		1,095		1,937
Marketable equity securities		17,149		20,895
Non-marketable equity securities		29,259		17,544
SAFEs		24,829		22,108
Total	$	119,944	$	112,188
Equity method investments (1):
BiomEdit, LLC	$	—	$	369
Other		1,120		1,174
Total	$	1,120	$	1,543

(1) Equity method investments in Platform Ventures with a carrying value of zero as of June 30, 2023 and December 31, 2022 were excluded from the table.

Losses on investments and equity method investments consisted of the following (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Loss on investments:
Synlogic, Inc. common stock	$	(1,281	)	$	(7,926	)	$	(2,092	)	$	(8,053	)
Synlogic, Inc. warrants		(514	)		(3,185	)		(841	)		(3,236	)
Genomatica, Inc.		—			(10,115	)		—			(10,115	)
Marketable equity securities		(326	)		(17,447	)		(3,747	)		(16,819	)
SAFEs		—			—			(1,811	)		—
Total	$	(2,121	)	$	(38,673	)	$	(8,491	)	$	(38,223	)
Loss on equity method investments:
Joyn Bio, LLC	$	—		$	(5,424	)	$	—		$	(10,411	)
Verb Biotics, LLC		—			—			—			(15,900	)
BiomEdit, LLC		—			(4,552	)		(1,462	)		(4,552	)
Other		(67	)		(190	)		(54	)		(190	)
Total	$	(67	)	$	(10,166	)	$	(1,516	)	$	(31,053	)